These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33335114)

  • 21. The regulation, functions and clinical relevance of arginine methylation.
    Guccione E; Richard S
    Nat Rev Mol Cell Biol; 2019 Oct; 20(10):642-657. PubMed ID: 31350521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells.
    Szewczyk MM; Vu V; Barsyte-Lovejoy D
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptidic transition state analogues as PRMT inhibitors.
    Zhang Y; van Haren MJ; Martin NI
    Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The story of protein arginine methylation: characterization, regulation, and function.
    Peng C; Wong CC
    Expert Rev Proteomics; 2017 Feb; 14(2):157-170. PubMed ID: 28043171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src.
    Ostareck-Lederer A; Ostareck DH; Rucknagel KP; Schierhorn A; Moritz B; Huttelmaier S; Flach N; Handoko L; Wahle E
    J Biol Chem; 2006 Apr; 281(16):11115-25. PubMed ID: 16492668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors.
    Ma M; Liu F; Miles HN; Kim EJ; Fields L; Xu W; Li L
    J Am Soc Mass Spectrom; 2023 Aug; 34(8):1692-1700. PubMed ID: 37463068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation.
    Wang C; Jiang H; Jin J; Xie Y; Chen Z; Zhang H; Lian F; Liu YC; Zhang C; Ding H; Chen S; Zhang N; Zhang Y; Jiang H; Chen K; Ye F; Yao Z; Luo C
    J Med Chem; 2017 Nov; 60(21):8888-8905. PubMed ID: 29019697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
    Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
    ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
    Fedoriw A; Shi L; O'Brien S; Smitheman KN; Wang Y; Hou J; Sherk C; Rajapurkar S; Laraio J; Williams LJ; Xu C; Han G; Feng Q; Bedford MT; Wang L; Barbash O; Kruger RG; Hwu P; Mohammad HP; Peng W
    Cancer Immunol Res; 2022 Apr; 10(4):420-436. PubMed ID: 35181787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the methylation preference region in heterogeneous nuclear ribonucleoprotein K by protein arginine methyltransferase 1 and its implication in regulating nuclear/cytoplasmic distribution.
    Chang YI; Hsu SC; Chau GY; Huang CY; Sung JS; Hua WK; Lin WJ
    Biochem Biophys Res Commun; 2011 Jan; 404(3):865-9. PubMed ID: 21184736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
    Hu H; Luo C; Zheng YG
    J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginine methylation and respiratory disease.
    Zhang B; Guan Y; Zeng D; Wang R
    Transl Res; 2024 Oct; 272():140-150. PubMed ID: 38453053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical probes for protein arginine methyltransferases.
    Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
    Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition.
    Shishkova E; Zeng H; Liu F; Kwiecien NW; Hebert AS; Coon JJ; Xu W
    Nat Commun; 2017 May; 8():15571. PubMed ID: 28537268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRMT-5 converts monomethylarginines into symmetrical dimethylarginines in Caenorhabditis elegans.
    Kanou A; Kako K; Hirota K; Fukamizu A
    J Biochem; 2017 Feb; 161(2):231-235. PubMed ID: 28173048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?
    Jarrold J; Davies CC
    Trends Mol Med; 2019 Nov; 25(11):993-1009. PubMed ID: 31230909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arginine Methylation: The Coming of Age.
    Blanc RS; Richard S
    Mol Cell; 2017 Jan; 65(1):8-24. PubMed ID: 28061334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of methylarginine-containing proteins in HeLa cells by two-dimensional gel electrophoresis and immunoblotting with a methylarginine-specific antibody.
    Hung CJ; Lee YJ; Chen DH; Li C
    Protein J; 2009 May; 28(3-4):139-47. PubMed ID: 19365714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assaying epigenome functions of PRMTs and their substrates.
    Rakow S; Pullamsetti SS; Bauer UM; Bouchard C
    Methods; 2020 Mar; 175():53-65. PubMed ID: 31542509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
    Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
    Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.